Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes

Figure 6

Alteration of apoAII isoforms after the incubation with pancreatic juice in PDAC patients after CRT (n=44). PDAC: pancreatic ductal adenocarcinoma, CRT: chemoradiotherapy, and PJ: pancreatic juice.

(a)

(b)

(c)

(d)